ArticleOncotarget2015

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.

Sabine Cerny-Reiterer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.